GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals

BACKGROUND: Glucagon-like peptide-1 (GLP-1) treatment has been shown to reduce stroke incidence in diabetes and also to be neuroprotective in experimental stroke models. The prognostic value of endogenous levels of GLP-1 in the recovery phase after stroke remains to be elucidated. The aim of the stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsson, Martin, Patrone, Cesare, von Euler, Mia, Holst, Jens J., Nathanson, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628501/
https://www.ncbi.nlm.nih.gov/pubmed/31307484
http://dx.doi.org/10.1186/s12933-019-0896-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628501/
https://www.ncbi.nlm.nih.gov/pubmed/31307484
http://dx.doi.org/10.1186/s12933-019-0896-z

Ejemplares similares